MRNA
Moderna Inc.
Company Overview
| Mkt Cap | $9.86B | Price | $27.16 |
| Volume | 15.70M | Change | -3.48% |
| P/E Ratio | -2.8 | Open | $27.83 |
| Revenue | $3.2B | Prev Close | $28.14 |
| Net Income | $-3.6B | 52W Range | $23.15 - $56.70 |
| Div Yield | N/A | Target | $39.60 |
| Overall | 70 | Value | 60 |
| Quality | -- | Technical | 81 |
No chart data available
Stock Overview
Updated DailyModerna Inc. (MRNA) is a leading Healthcare company in the Biotechnology industry, currently trading at $27.16 with a market capitalization of $9.86 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows MRNA with a volume of 15.70 million shares. The stock opened down 1.12% from yesterday's close of $28.14. Current analyst estimates project earnings of $-9.73 per share for this year, with next year targeting $-7.26.
MRNA demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including RGLS, MRK, ATHX, MON, NVS.
Key investment considerations for MRNA include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 45.8%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 03:07 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MRNA | $27.16 | -3.5% | 15.70M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |